Full Text
PSS10 COST PER RESPONDER OF USTEKINUMAB VERSUS ETANERCEPT IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS- ANALYSIS FROM THE ACCEPT TRIAL

Abstract

Authors

SR Feldman M Augustin S Martin P Szapary B Schenkel

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×